Premium
Clinical aspects of fertility preservation in female patients
Author(s) -
RodriguezMacias Wallberg Kenny A.,
Keros Victoria,
Hovatta Outi
Publication year - 2009
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.21995
Subject(s) - fertility preservation , medicine , fertility , infertility , disease , ovarian tissue cryopreservation , ovarian tissue , stage (stratigraphy) , ovarian cancer , cancer , female infertility , intensive care medicine , gynecology , pregnancy , ovary , population , paleontology , environmental health , biology , genetics
There are several methods of fertility preservation available for female patients facing infertility following gonadotoxic treatment of cancer or systemic disease. Embryos, oocytes or ovarian tissue can be cryopreserved and stored until the time when the patient is cured of her main disease and is expecting parenthood. The individual's choice depends on the nature and stage of the main disease, expected treatment, their condition, and age and existence of the partner. It is important to inform all such women about the options, and together with them, choose the most appropriate ones. It is often possible to save ovarian tissue even though the first chemotherapy courses have been undergone, but many more follicles can be stored before cancer treatment. Pediatr Blood Cancer 2009;53:254–260. © 2009 Wiley‐Liss, Inc.